Mark Lappe, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), sold 302,057 shares at $8.94 ($2.8M) on 2008-03-20, disclosed to the SEC on 2008-07-03.
Open-market sale of $2.8M RPRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.59 | 26,300 | $226K | 8.1% |
| 2 | $8.54 | 55,357 | $473K | 17.0% |
| 3 | $8.90 | 10,600 | $94K | 3.4% |
| 4 | $8.94 | 34,000 | $304K | 10.9% |
| 5 | $9.61 | 50,000 | $481K | 17.3% |
| 6 | $9.58 | 60,000 |
| $575K |
| 20.7% |
| 7 | $9.82 | 10,000 | $98K | 3.5% |
| 8 | $9.55 | 55,800 | $533K | 19.1% |
| Total | $9.21 avg | 302,057 | $2.8M | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |